Date Announced: 19 Aug 2019. Precise and cost-effective fabrication of today’s complex stents requires an ultrashort pulse laser. Birkerød, Denmark -- When stent material transitioned from stainless ...

In its latest study to offer insight into the safety of drug-eluting stents, Boston Scientific revealed favorable findings about its Taxus device at a cardiovascular conference yesterday. Partially ...

A drug-eluting resorbable scaffold was superior to angioplasty in treating infrapopliteal artery disease and chronic limb-threating ischemia and was noninferior for safety in the LIFE-BTK trial.

Considerably lower risk of stent thrombosis and restenosis in 'new generation' drug-eluting stents Aug 30, 2011 An 'important' reduction in risk of stent thrombosis with everolimus-eluting stent ...

Compared with plain old balloon angioplasty (POBA), drug-eluting stent and drug-coated balloon (DCB) technologies do not improve amputation-free survival in patients with chronic limb-threatening ...

Elixir Medical’s DynamX Bioadaptor Demonstrates Significant Improvement Over Contemporary Drug-Eluting Stent in Patients with Acute Coronary Syndrome and Complex Lesion Subsets After Six Months ...

SAN FRANCISCO — The first-time application of a triple-drug, site-specific antithrombotic therapy on a stent platform was safe and effective for managing thrombotic and bleeding risk after PCI ...

Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label ...

Mar. 23 -- TUESDAY, July 10 (HealthDay News) -- Nearly a third of patients who had drug-coated stents implanted in vein grafts to improve coronary blood flow died within 32 months, Dutch ...

Interest in stenting for the treatment of symptomatic high-grade intracranial atherosclerosis may be rekindled after the results of a new trial using a drug-eluting stent.